{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:10Z","timestamp":1791919990042,"version":"4.3.4"},"reference-count":171,"publisher":"Bentham Science Publishers Ltd.","issue":"29","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>The Flaviviridae virus family consists of the genera Hepacivirus, Pestivirus, and Fla-vivirus, with approximately 70 viral types that use arthropods as vectors. Among these diseases, dengue (DENV) and zika virus (ZIKV) serotypes stand out, responsible for thousands of deaths worldwide. Due to the significant increase in cases, the World Health Organization (WHO) declared DENV a potential threat for 2019 due to being transmitted by infected travelers. Furthermore, ZIKV also has a high rate of transmissibility, highlighted in the outbreak in 2015, generating consequenc-es such as Guillain-Barr\u00e9 syndrome and microcephaly. According to clinical outcomes, those in-fected with DENV can be asymptomatic, and in other cases, it can be lethal. On the other hand, ZIKV has severe neurological symptoms in newborn babies and adults. More serious symptoms in-clude microcephaly, brain calcifications, intrauterine growth restriction, and fetal death. Despite these worrying data, no drug or vaccine is approved to treat these diseases. In the drug discovery process, one of the targets explored against these diseases is the NS2B-NS3 complex, which pre-sents the catalytic triad His51, Asp75, and Ser135, with the function of cleaving polyproteins, with specificity for basic amino acid residues, Lys- Arg, Arg-Arg, Arg-Lys or Gln-Arg. Since NS3 is highly conserved in all DENV serotypes and plays a vital role in viral replication, this complex is an excellent drug target. In recent years, computer-aided drug discovery (CADD) is increasingly essen-tial in drug discovery campaigns, making the process faster and more cost-effective, mainly ex-plained by discovering new drugs against DENV and ZIKV. Finally, the main advances in compu-tational methods applied to discover new compounds against these diseases will be presented here. In fact, molecular dynamics simulations and virtual screening is the most explored approach, providing several hit and lead compounds that can be used in further optimizations. In addition, fragment-based drug design and quantum chemistry\/molecular mechanics (QM\/MM) provides new insights for developing anti-DENV\/ZIKV drugs. We hope that this review offers further helpful in-formation for researchers worldwide and stimulates the use of computational methods to find a promising drug for treating DENV and ZIKV.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026623666221122121330","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:33:51Z","timestamp":1669178031000},"page":"2435-2462","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2664-4336","authenticated-orcid":true,"given":"Igor Jos\u00e9","family":"dos Santos Nascimento","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Est\u00e1cio of Alagoas College, Macei\u00f3, Brazil"},{"name":"Department of Pharmacy, Cesmac University Center, Macei\u00f3, Brazil"},{"name":"Department of Pharmacy, Drug Development and Synthesis Laboratory, State University of Para\u00edba, Campina Grande, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-6478","authenticated-orcid":true,"given":"\u00c9rica Erlanny","family":"da Silva Rodrigues","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Pharmaceutical Sciences Institute, Federal University of Alagoas, Macei\u00f3, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1818-5368","authenticated-orcid":true,"given":"Manuele Figueiredo","family":"da Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Pharmaceutical Sciences Institute, Federal University of Alagoas, Macei\u00f3, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-183X","authenticated-orcid":true,"given":"Jo\u00e3o Xavier","family":"de Ara\u00fajo-J\u00fanior","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Pharmaceutical Sciences Institute, Federal University of Alagoas, Macei\u00f3, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-3750","authenticated-orcid":true,"given":"Ricardo Olimpio","family":"de Moura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Drug Development and Synthesis Laboratory, State University of Para\u00edba, Campina Grande, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10096-018-3375-7","volume":"38","author":"Sukhralia S.","year":"2019","unstructured":"Sukhralia S.; Verma M.; Gopirajan S.; Dhanaraj P.S.; Lal R.; Mehla N.; Kant C.R.; From dengue to Zika: The wide spread of mosquito-borne arboviruses. Eur J Clin Microbiol Infect Dis 2019,38(1),3-14","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/tropicalmed5040150","volume":"5","author":"Silva N.M.","year":"2020","unstructured":"Silva N.M.; Santos N.C.; Martins I.C.; Dengue and Zika Viruses: Epidemiological history, potential therapies, and promising vaccines. Trop Med Infect Dis 2020,5(4),150","journal-title":"Trop Med Infect Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"11302","DOI":"10.1038\/s41598-020-68357-9","volume":"10","author":"Versiani A.F.","year":"2020","unstructured":"Versiani A.F.; Martins E.M.N.; Andrade L.M.; Cox L.; Pereira G.C.; Barbosa-Stancioli E.F.; Nogueira M.L.; Ladeira L.O.; da Fonseca F.G.; Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections. Sci Rep 2020,10(1),11302","journal-title":"Sci Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41467-019-09391-8","volume":"10","author":"Huber R.G.","year":"2019","unstructured":"Huber R.G.; Lim X.N.; Ng W.C.; Sim A.Y.L.; Poh H.X.; Shen Y.; Lim S.Y.; Sundstrom K.B.; Sun X.; Aw J.G.; Too H.K.; Boey P.H.; Wilm A.; Chawla T.; Choy M.M.; Jiang L.; de Sessions P.F.; Loh X.J.; Alonso S.; Hibberd M.; Nagarajan N.; Ooi E.E.; Bond P.J.; Sessions O.M.; Wan Y.; Structure mapping of dengue and Zika viruses reveals functional long-range interactions. Nat Commun 2019,10(1),1408","journal-title":"Nat Commun"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ecolmodel.2018.09.004","volume":"387","author":"Zheng B.","year":"2018","unstructured":"Zheng B.; Yu J.; Xi Z.; Tang M.; The annual abundance of dengue and Zika vector Aedes albopictus and its stubbornness to suppression. Ecol Modell 2018,387,38-48","journal-title":"Ecol Modell"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"113698","DOI":"10.1016\/j.ejmech.2021.113698","volume":"224","author":"Nascimento I.J.S.","year":"2021","unstructured":"Nascimento I.J.S.; Santos-J&#xFA;nior P.F.S.; Aquino T.M.; Ara&#xFA;jo-J&#xFA;nior J.X.; Silva-J&#xFA;nior E.F.; Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors. Eur J Med Chem 2021,224,113698","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00604-019-3420-y","volume":"186","author":"Eivazzadeh-Keihan R.","year":"2019","unstructured":"Eivazzadeh-Keihan R.; Pashazadeh-Panahi P.; Mahmoudi T.; Chenab K.K.; Baradaran B.; Hashemzaei M.; Radinekiyan F.; Mokhtarzadeh A.; Maleki A.; Dengue virus: a review on advances in detection and trends\u2013from conventional methods to novel biosensors. Mikrochim Acta 2019,186(6),329","journal-title":"Mikrochim Acta"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","volume":"19","author":"St John A.L.","year":"2019","unstructured":"St John A.L.; Rathore A.P.S.; Adaptive immune responses to primary and secondary dengue virus infections. Nat Rev Immunol 2019,19(4),218-230","journal-title":"Nat Rev Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","volume":"43","author":"Troost B.","year":"2020","unstructured":"Troost B.; Smit J.M.; Recent advances in antiviral drug development towards dengue virus. Curr Opin Virol 2020,43,9-21","journal-title":"Curr Opin Virol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2018.12.002","volume":"162","author":"Balasubramanian A.","year":"2019","unstructured":"Balasubramanian A.; Pilankatta R.; Teramoto T.; Sajith A.M.; Nwulia E.; Kulkarni A.; Padmanabhan R.; Inhibition of dengue virus by curcuminoids. Antiviral Res 2019,162,71-78","journal-title":"Antiviral Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00284-020-02284-w","volume":"78","author":"Bhatt P.","year":"2021","unstructured":"Bhatt P.; Sabeena S.P.; Varma M.; Arunkumar G.; Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol 2021,78(1),17-32","journal-title":"Curr Microbiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ph12040157","volume":"12","author":"Basak S.C.","year":"2019","unstructured":"Basak S.C.; Majumdar S.; Nandy A.; Roy P.; Dutta T.; Vracko M.; Bhattacharjee A.K.; Computer-assisted and data driven approaches for surveillance, drug discovery, and vaccine design for the Zika Virus. Pharmaceuticals (Basel) 2019,12(4),157","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.drudis.2018.06.014","volume":"23","author":"Mottin M.","year":"2018","unstructured":"Mottin M.; Borba J.V.V.B.; Braga R.C.; Torres P.H.M.; Martini M.C.; Proenca-Modena J.L.; Judice C.C.; Costa F.T.M.; Ekins S.; Perryman A.L.; Horta Andrade C.; The A\u2013Z of Zika drug discovery. Drug Discov Today 2018,23(11),1833-1847","journal-title":"Drug Discov Today"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.1038\/s41598-020-65489-w","volume":"10","author":"Pathak N.","year":"2020","unstructured":"Pathak N.; Kuo Y.P.; Chang T.Y.; Huang C.T.; Hung H.C.; Hsu J.T.A.; Yu G.Y.; Yang J.M.; Zika Virus NS3 Protease pharmacophore anchor model and drug discovery. Sci Rep 2020,10(1),8929","journal-title":"Sci Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"198388","DOI":"10.1016\/j.virusres.2021.198388","volume":"299","author":"Fernandes R.S.","year":"2021","unstructured":"Fernandes R.S.; de Godoy A.S.; Santos I.A.; Noske G.D.; de Oliveira K.I.Z.; Gawriljuk V.O.; Gomes Jardim A.C.; Oliva G.; Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening. Virus Res 2021,299,198388","journal-title":"Virus Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"110655","DOI":"10.1016\/j.celrep.2022.110655","volume":"39","author":"Regla-Nava J.A.","year":"2022","unstructured":"Regla-Nava J.A.; Wang Y.T.; Fontes-Garfias C.R.; Liu Y.; Syed T.; Susantono M.; Gonzalez A.; Viramontes K.M.; Verma S.K.; Kim K.; Landeras-Bueno S.; Huang C.T.; Prigozhin D.M.; Gleeson J.G.; Terskikh A.V.; Shi P.Y.; Shresta S.; A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity. Cell Rep 2022,39(2),110655","journal-title":"Cell Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.coviro.2019.01.005","volume":"35","author":"Zou J.","year":"2019","unstructured":"Zou J.; Shi P.Y.; Strategies for Zika drug discovery. Curr Opin Virol 2019,35,19-26","journal-title":"Curr Opin Virol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pbiomolbio.2018.08.009","volume":"143","author":"Lim L.","year":"2019","unstructured":"Lim L.; Gupta G.; Roy A.; Kang J.; Srivastava S.; Shi J.; Song J.; Structurally- and dynamically-driven allostery of the chymotrypsin-like proteases of SARS, Dengue and Zika viruses. Prog Biophys Mol Biol 2019,143,52-66","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jmv.27386","volume":"94","author":"Nunes D.A.F.","year":"2022","unstructured":"Nunes D.A.F.; Santos F.R.S.; da Fonseca S.T.D.; de Lima W.G.; Nizer W.S.C.; Ferreira J.M.S.; de Magalh&#xE3;es J.C.; NS2B\u2010NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review. J Med Virol 2022,94(2),442-453","journal-title":"J Med Virol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1021\/acs.jmedchem.1c01860","volume":"65","author":"Huber S.","year":"2022","unstructured":"Huber S.; Braun N.J.; Schmacke L.C.; Quek J.P.; Murra R.; Bender D.; Hildt E.; Luo D.; Heine A.; Steinmetzer T.; Structure-based optimization and characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors. J Med Chem 2022,65(9),6555-6572","journal-title":"J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"113767","DOI":"10.1016\/j.ejmech.2021.113767","volume":"225","author":"Nie S.","year":"2021","unstructured":"Nie S.; Zhao J.; Wu X.; Yao Y.; Wu F.; Lin Y.L.; Li X.; Kneubehl A.R.; Vogt M.B.; Rico-Hesse R.; Song Y.; Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease. Eur J Med Chem 2021,225,113767","journal-title":"Eur J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"116392","DOI":"10.1016\/j.bmc.2021.116392","volume":"47","author":"Maus H.","year":"2021","unstructured":"Maus H.; Barthels F.; Hammerschmidt S.J.; Kopp K.; Millies B.; Gellert A.; Ruggieri A.; Schirmeister T.; SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B\/NS3 proteases. Bioorg Med Chem 2021,47,116392","journal-title":"Bioorg Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"104900","DOI":"10.1016\/j.antiviral.2020.104900","volume":"182","author":"Phoo W.W.","year":"2020","unstructured":"Phoo W.W.; El Sahili A.; Zhang Z.; Chen M.W.; Liew C.W.; Lescar J.; Vasudevan S.G.; Luo D.; Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3. Antiviral Res 2020,182,104900","journal-title":"Antiviral Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.biochi.2019.05.004","volume":"166","author":"Majerov&#xE1; T.","year":"2019","unstructured":"Majerov&#xE1; T.; Novotn&#xFD; P.; Kr&#xFD;sov&#xE1; E.; Konvalinka J.; Exploiting the unique features of Zika and Dengue proteases for inhibitor design. Biochimie 2019,166,132-141","journal-title":"Biochimie"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2174\/0929867327666200812215852","volume":"28","author":"dos Santos Nascimento I.J.","year":"2021","unstructured":"dos Santos Nascimento I.J.; de Aquino T.M.; da Silva-J&#xFA;nior E.F.; Drug Repurposing: A strategy for discovering inhibitors against emerging viral infections. Curr Med Chem 2021,28(15),2887-2942","journal-title":"Curr Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2174\/1570180819666220405225817","volume":"19","author":"Nascimento I.J.S.","year":"2022","unstructured":"Nascimento I.J.S.; de Aquino T.M.; da Silva-J&#xFA;nior E.F.; The new era of drug discovery: The power of computer-aided drug design (CADD). Lett Drug Des Discov 2022,19(11),951-955","journal-title":"Lett Drug Des Discov"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/9789811457791120050004","volume":"5","author":"Jos&#xE9; dos Santos Nascimento I.","year":"2020","unstructured":"Jos&#xE9; dos Santos Nascimento I.; Mendon&#xE7;a de Aquino T.; Fernando da Silva Santos-J&#xFA;nior P.; Xavier de Ara&#xFA;jo-J&#xFA;nior J.; Ferreira da Silva-J&#xFA;nior E.; Molecular modeling applied to design of cysteine protease inhibitors \u2013 a powerful tool for the identification of hit compounds against neglected tropical diseases. Front Comput Chem 2020,5,63-110","journal-title":"Front Comput Chem"},{"key":"ref=28","first-page":"2317","volume":"25","author":"Dos Santos Nascimento I.J.","year":"2021","unstructured":"Dos Santos Nascimento I.J.; da Silva-J&#xFA;nior E.F.; TNF-&#x3B1; Inhibitors from natural compounds: An overview, CADD approaches, and their exploration for anti-inflammatory agents. Comb Chem High Throughput Screen 2021,25(14),2317-2340","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=29","author":"dos Santos Nascimento I.J.","year":"2022","unstructured":"dos Santos Nascimento I.J.; de Aquino T.M.; da Silva-J&#xFA;nior E.F.; Molecular docking and dynamics simulations studies of a dataset of NLRP3 inflammasome inhibitors [Epub ahead of print].2022","journal-title":"Molecular docking and dynamics simulations studies of a dataset of NLRP3 inflammasome inhibitors"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1389450122666210809090909","volume":"23","author":"dos Santos Nascimento I.J.","year":"2021","unstructured":"dos Santos Nascimento I.J.; da Silva-J&#xFA;nior E.F.; de Aquino T.M.; Molecular modeling targeting transmembrane Serine Protease 2 (TMPRSS2) as an alternative drug target against Coronaviruses. Curr Drug Targets 2021,23(3),240-259","journal-title":"Curr Drug Targets"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2174\/1570180819666220106110133","volume":"19","author":"Santos Nascimento I.J.","year":"2022","unstructured":"Santos Nascimento I.J.; Silva-J&#xFA;nior E.F.; Aquino T.M.; Repurposing FDA-approved drugs targeting SARS-CoV2 3CL pro: A study by applying virtual screening, molecular dynamics, MM-PBSA calculations and covalent docking. Lett Drug Des Discov 2022,19(7),637-653","journal-title":"Lett Drug Des Discov"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.2174\/0929867329666220317122948","volume":"29","author":"dos Santos Nascimento I.J.","year":"2022","unstructured":"dos Santos Nascimento I.J.; de Aquino T.M.; da Silva J&#xFA;nior E.F.; Computer-aided drug design of anti-inflammatory agents targeting microsomal prostaglandin E2 synthase-1 (mPGES-1). Curr Med Chem 2022,29(33),5397-5419","journal-title":"Curr Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11262-022-01898-5","volume":"58","author":"Sundar S.","year":"2022","unstructured":"Sundar S.; Piramanayagam S.; Natarajan J.; A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika. Virus Genes 2022,58(3),151-171","journal-title":"Virus Genes"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s42250-022-00361-0","volume":"5","author":"Adawara S.N.","year":"2022","unstructured":"Adawara S.N.; Shallangwa G.A.; Mamza P.A.; Abdulkadir I.; Computer-aided drug design and ADMET of novel potent dengue virus NS-5 inhibitors. Chem Africa 2022,5,855-869","journal-title":"Chem Africa"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1021\/acsmedchemlett.8b00583","volume":"10","author":"Vincetti P.","year":"2019","unstructured":"Vincetti P.; Kaptein S.J.F.; Costantino G.; Neyts J.; Radi M.; Scaffold morphing approach to expand the toolbox of broad-spectrum antivirals blocking dengue\/zika replication. ACS Med Chem Lett 2019,10(4),558-563","journal-title":"ACS Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/15476286.2020.1868754","volume":"18","author":"Jansen S.","year":"2021","unstructured":"Jansen S.; Smlatic E.; Copmans D.; Debaveye S.; Tangy F.; Vidalain P.O.; Neyts J.; Dallmeier K.; Identification of host factors binding to dengue and Zika virus subgenomic RNA by efficient yeast three-hybrid screens of the human ORFeome. RNA Biol 2021,18(5),732-744","journal-title":"RNA Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","volume":"22","author":"Messina J.P.","year":"2014","unstructured":"Messina J.P.; Brady O.J.; Scott T.W.; Zou C.; Pigott D.M.; Duda K.A.; Bhatt S.; Katzelnick L.; Howes R.E.; Battle K.E.; Simmons C.P.; Hay S.I.; Global spread of dengue virus types: Mapping the 70 year history. Trends Microbiol 2014,22(3),138-146","journal-title":"Trends Microbiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jinf.2015.10.007","volume":"72","author":"Sun J.","year":"2016","unstructured":"Sun J.; Wu D.; Zhou H.; Zhang H.; Guan D.; He X.; Cai S.; Ke C.; Lin J.; The epidemiological characteristics and genetic diversity of dengue virus during the third largest historical outbreak of dengue in Guangdong, China, in 2014. J Infect 2016,72(1),80-90","journal-title":"J Infect"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"101471","DOI":"10.1016\/j.tmaid.2019.101471","volume":"31","author":"Halstead S.B.","year":"2019","unstructured":"Halstead S.B.; Travelling arboviruses: A historical perspective. Travel Med Infect Dis 2019,31,101471","journal-title":"Travel Med Infect Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/ijd.13399","volume":"55","author":"Mlacker S.","year":"2016","unstructured":"Mlacker S.; Shafa G.; Aldahan A.S.; Shah V.V.; Samarkandy S.; Nouri K.; Origin of the Zika virus revealed: a historical journey across the world. Int J Dermatol 2016,55(12),1369-1372","journal-title":"Int J Dermatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e000087","DOI":"10.1136\/bmjgh-2016-000087","volume":"1","author":"Posen H.J.","year":"2016","unstructured":"Posen H.J.; Keystone J.S.; Gubbay J.B.; Morris S.K.; Epidemiology of Zika virus, 1947\u20132007. BMJ Glob Health 2016,1(2),e000087","journal-title":"BMJ Glob Health"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.virol.2017.12.003","volume":"516","author":"Bos S.","year":"2018","unstructured":"Bos S.; Viranaicken W.; Turpin J.; El-Kalamouni C.; Roche M.; Krejbich-Trotot P.; Despr&#xE8;s P.; Gadea G.; The structural proteins of epidemic and historical strains of Zika virus differ in their ability to initiate viral infection in human host cells. Virology 2018,516,265-273","journal-title":"Virology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5501\/wjv.v6.i1.1","volume":"6","author":"Armstrong N.","year":"2017","unstructured":"Armstrong N.; Hou W.; Tang Q.; Biological and historical overview of Zika virus. World J Virol 2017,6(1),1-8","journal-title":"World J Virol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1745-7270.2008.00382.x","volume":"40","author":"Qi R.","year":"2008","unstructured":"Qi R.; Zhang L.; Chi C.; Biological characteristics of dengue virus and potential targets for drug design. Acta Biochim Biophys Sin (Shanghai) 2008,40(2),91-101","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1067","volume":"3","author":"Mukhopadhyay S.","year":"2005","unstructured":"Mukhopadhyay S.; Kuhn R.J.; Rossmann M.G.; A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005,3(1),13-22","journal-title":"Nat Rev Microbiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","volume":"67","author":"Rodenhuis-Zybert I.A.","year":"2010","unstructured":"Rodenhuis-Zybert I.A.; Wilschut J.; Smit J.M.; Dengue virus life cycle: Viral and host factors modulating infectivity. Cell Mol Life Sci 2010,67(16),2773-2786","journal-title":"Cell Mol Life Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/v10100559","volume":"10","author":"Sager G.","year":"2018","unstructured":"Sager G.; Gabaglio S.; Sztul E.; Belov G.; Role of host cell secretory machinery in zika virus life cycle. Viruses 2018,10(10),559","journal-title":"Viruses"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S1286-4579(00)01258-2","volume":"2","author":"McBride W.J.H.","year":"2000","unstructured":"McBride W.J.H.; Bielefeldt-Ohmann H.; Dengue viral infections; Pathogenesis and epidemiology. Microbes Infect 2000,2(9),1041-1050","journal-title":"Microbes Infect"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/vaccines9090946","volume":"9","author":"Lebeau G.","year":"2021","unstructured":"Lebeau G.; Lagrave A.; Ogire E.; Grondin L.; Seriacaroupin S.; Moutoussamy C.; Mavingui P.; Hoarau J.J.; Roche M.; Krejbich-Trotot P.; Despr&#xE8;s P.; Viranaicken W.; Viral Toxin NS1 implication in dengue pathogenesis making it a pivotal target in development of efficient vaccine. Vaccines (Basel) 2021,9(9),946","journal-title":"Vaccines (Basel)"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40475-019-00191-0","volume":"6","author":"Giraldo-Garc&#xED;a A.M.","year":"2019","unstructured":"Giraldo-Garc&#xED;a A.M.; Casta&#xF1;o-Osorio J.C.; Effects of flavivirus cross-reactivity (zika and dengue) on the development of vaccines for use in pregnancy. Curr Trop Med Rep 2019,6(4),223-230","journal-title":"Curr Trop Med Rep"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s11239-020-02082-y","volume":"49","author":"Poletto F.","year":"2020","unstructured":"Poletto F.; Cerruti L.; Spiezia L.; Dengue fever as a rare cause of pulmonary embolism. J Thromb Thrombolysis 2020,49(4),690-693","journal-title":"J Thromb Thrombolysis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"101474","DOI":"10.1016\/j.ajoc.2022.101474","volume":"26","author":"Translateur A.","year":"2022","unstructured":"Translateur A.; Perez-Rueda M.; Acute macular neuroretinopathy associated to dengue disease. Am J Ophthalmol Case Rep 2022,26,101474","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.paed.2018.10.010","volume":"29","author":"Oeser C.","year":"2019","unstructured":"Oeser C.; Ladhani S.; An update on zika virus and congenital zika syndrome. Paediatr Child Health (Oxford) 2019,29(1),34-37","journal-title":"Paediatr Child Health (Oxford)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41585-019-0149-7","volume":"16","author":"Kurscheidt F.A.","year":"2019","unstructured":"Kurscheidt F.A.; Mesquita C.S.S.; Damke G.M.Z.F.; Damke E.; Carvalho A.R.B.A.; Suehiro T.T.; Teixeira J.J.V.; da Silva V.R.S.; Souza R.P.; Consolaro M.E.L.; Persistence and clinical relevance of Zika virus in the male genital tract. Nat Rev Urol 2019,16(4),211-230","journal-title":"Nat Rev Urol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"104205","DOI":"10.1016\/j.bioorg.2020.104205","volume":"104","author":"Xu B.","year":"2020","unstructured":"Xu B.; Lee E.M.; Medina A.; Sun X.; Wang D.; Tang H.; Zhou G.C.; Inhibition of Zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one. Bioorg Chem 2020,104,104205","journal-title":"Bioorg Chem"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1684\/ecn.2019.0433","volume":"30","author":"Maucourant C.","year":"2019","unstructured":"Maucourant C.; Queiroz G.A.N.; Samri A.; Grassi M.F.R.; Yssel H.; Vieillard V.; Zika virus in the eye of the cytokine storm. Eur Cytokine Netw 2019,30(3),74-81","journal-title":"Eur Cytokine Netw"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virusres.2017.01.020","volume":"234","author":"Lu G.","year":"2017","unstructured":"Lu G.; Gong P.; A structural view of the RNA-dependent RNA polymerases from the Flavivirus genus. Virus Res 2017,234,34-43","journal-title":"Virus Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jprot.2014.06.002","volume":"111","author":"Salazar M.I.","year":"2014","unstructured":"Salazar M.I.; del Angel R.M.; Lanz-Mendoza H.; Ludert J.E.; Pando-Robles V.; The role of cell proteins in dengue virus infection. J Proteomics 2014,111,6-15","journal-title":"J Proteomics"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.antiviral.2012.09.007","volume":"96","author":"Noble C.G.","year":"2012","unstructured":"Noble C.G.; Shi P.Y.; Structural biology of dengue virus enzymes: Towards rational design of therapeutics. Antiviral Res 2012,96(2),115-126","journal-title":"Antiviral Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gene.2019.02.001","volume":"695","author":"Verma M.","year":"2019","unstructured":"Verma M.; Bhatnagar S.; Kumari K.; Mittal N.; Sukhralia S.; Gopirajan AT, S.; Dhanaraj P.S.; Lal R.; Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets. Gene 2019,695,18-25","journal-title":"Gene"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.sintl.2020.100030","volume":"1","author":"Dhal A.","year":"2020","unstructured":"Dhal A.; Kalyani T.; Ghorai S.; Sahu N.K.; Jana S.K.; Recent development of electrochemical immunosensor for the diagnosis of dengue virus NSI protein: A review. Sens Int 2020,1,100030","journal-title":"Sens Int"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02957-12","volume":"87","author":"Klein D.E.","year":"2013","unstructured":"Klein D.E.; Choi J.L.; Harrison S.C.; Structure of a dengue virus envelope protein late-stage fusion intermediate. J Virol 2013,87(4),2287-2293","journal-title":"J Virol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1128\/jvi.70.12.8765-8772.1996","volume":"70","author":"Chen Y.","year":"1996","unstructured":"Chen Y.; Maguire T.; Marks R.M.; Demonstration of binding of dengue virus envelope protein to target cells. J Virol 1996,70(12),8765-8772","journal-title":"J Virol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"Kuhn R.J.","year":"2002","unstructured":"Kuhn R.J.; Zhang W.; Rossmann M.G.; Pletnev S.V.; Corver J.; Lenches E.; Jones C.T.; Mukhopadhyay S.; Chipman P.R.; Strauss E.G.; Baker T.S.; Strauss J.H.; Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002,108(5),717-725","journal-title":"Cell"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1073\/pnas.1317350111","volume":"111","author":"Messer W.B.","year":"2014","unstructured":"Messer W.B.; de Alwis R.; Yount B.L.; Royal S.R.; Huynh J.P.; Smith S.A.; Crowe J.E.; Doranz B.J.; Kahle K.M.; Pfaff J.M.; White L.J.; Sariol C.A.; de Silva A.M.; Baric R.S.; Dengue virus envelope protein domain I\/II hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci USA 2014,111(5),1939-1944","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Modis Y.","year":"2004","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; Structure of the dengue virus envelope protein after membrane fusion. Nature 2004,427(6972),313-319","journal-title":"Nature"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41467-020-14647-9","volume":"11","author":"Tan T.Y.","year":"2020","unstructured":"Tan T.Y.; Fibriansah G.; Kostyuchenko V.A.; Ng T.S.; Lim X.X.; Zhang S.; Lim X.N.; Wang J.; Shi J.; Morais M.C.; Corti D.; Lok S.M.; Capsid protein structure in Zika virus reveals the flavivirus assembly process. Nat Commun 2020,11(1),895","journal-title":"Nat Commun"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e1000632","DOI":"10.1371\/journal.ppat.1000632","volume":"5","author":"Samsa M.M.","year":"2009","unstructured":"Samsa M.M.; Mondotte J.A.; Iglesias N.G.; Assun&#xE7;&#xE3;o-Miranda I.; Barbosa-Lima G.; Da Poian A.T.; Bozza P.T.; Gamarnik A.V.; Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog 2009,5(10),e1000632","journal-title":"PLoS Pathog"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.01429-12","volume":"57","author":"Byrd C.M.","year":"2013","unstructured":"Byrd C.M.; Dai D.; Grosenbach D.W.; Berhanu A.; Jones K.F.; Cardwell K.B.; Schneider C.; Wineinger K.A.; Page J.M.; Harver C.; Stavale E.; Tyavanagimatt S.; Stone M.A.; Bartenschlager R.; Scaturro P.; Hruby D.E.; Jordan R.; A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 2013,57(1),15-25","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jmb.2018.02.006","volume":"430","author":"Shang Z.","year":"2018","unstructured":"Shang Z.; Song H.; Shi Y.; Qi J.; Gao G.F.; Crystal Structure of the Capsid Protein from Zika Virus. J Mol Biol 2018,430(7),948-962","journal-title":"J Mol Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.3390\/ijms20163870","volume":"20","year":"2019","unstructured":"Faustino; Martins; Karguth; Artilheiro; Enguita; Ricardo; Santos; Martins, Structural and functional properties of the capsid protein of dengue and related flavivirus. Int J Mol Sci 2019,20(16),3870","journal-title":"Int J Mol Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"17992","DOI":"10.1073\/pnas.2003056117","volume":"117","author":"Xia H.","year":"2020","unstructured":"Xia H.; Xie X.; Zou J.; Noble C.G.; Russell W.K.; Holthauzen L.M.F.; Choi K.H.; White M.A.; Shi P.Y.; A cocrystal structure of dengue capsid protein in complex of inhibitor. Proc Natl Acad Sci USA 2020,117(30),17992-18001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1099\/vir.0.19163-0","volume":"84","author":"Catteau A.","year":"2003","unstructured":"Catteau A.; Kalinina O.; Wagner M.C.; Deubel V.; Courageot M.P.; Despr&#xE8;s P.; Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol 2003,84(10),2781-2793","journal-title":"J Gen Virol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e00996","DOI":"10.1128\/JVI.00996-19","volume":"93","author":"Pan P.","year":"2019","unstructured":"Pan P.; Zhang Q.; Liu W.; Wang W.; Lao Z.; Zhang W.; Shen M.; Wan P.; Xiao F.; Liu F.; Zhang W.; Tan Q.; Liu X.; Wu K.; Liu Y.; Li G.; Wu J.; Dengue Virus M protein promotes NLRP3 inflammasome activation to induce vascular leakage in mice. J Virol 2019,93(21),e00996-e009919","journal-title":"J Virol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.tibs.2017.02.009","volume":"42","author":"Shi Y.","year":"2017","unstructured":"Shi Y.; Gao G.F.; Structural biology of the Zika virus. Trends Biochem Sci 2017,42(6),443-456","journal-title":"Trends Biochem Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00232-005-0744-9","volume":"204","author":"Premkumar A.","year":"2005","unstructured":"Premkumar A.; Horan C.R.; Gage P.W.; Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels. J Membr Biol 2005,204(1),33-38","journal-title":"J Membr Biol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coviro.2020.08.006","volume":"43","author":"Katzelnick L.C.","year":"2020","unstructured":"Katzelnick L.C.; Bos S.; Harris E.; Protective and enhancing interactions among dengue viruses 1-4 and Zika virus. Curr Opin Virol 2020,43,59-70","journal-title":"Curr Opin Virol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"198065","DOI":"10.1016\/j.virusres.2020.198065","volume":"286","author":"Nambala P.","year":"2020","unstructured":"Nambala P.; Yu W.Y.; Lo Y.C.; Lin C.W.; Su W.C.; Ubiquitination of Zika virus precursor membrane protein promotes the release of viral proteins. Virus Res 2020,286,198065","journal-title":"Virus Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nsb990","volume":"10","author":"Zhang W.","year":"2003","unstructured":"Zhang W.; Chipman P.R.; Corver J.; Johnson P.R.; Zhang Y.; Mukhopadhyay S.; Baker T.S.; Strauss J.H.; Rossmann M.G.; Kuhn R.J.; Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Mol Biol 2003,10(11),907-912","journal-title":"Nat Struct Mol Biol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3389\/fimmu.2019.01651","volume":"10","author":"Reyes-Sandoval A.","year":"2019","unstructured":"Reyes-Sandoval A.; Ludert J.E.; The dual role of the antibody response against the flavivirus non-structural protein 1 (NS1) in protection and immuno-pathogenesis. Front Immunol 2019,10,1651","journal-title":"Front Immunol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejmech.2018.07.014","volume":"156","author":"Qadir A.","year":"2018","unstructured":"Qadir A.; Riaz M.; Saeed M.; Shahzad-ul-Hussan S.; Potential targets for therapeutic intervention and structure based vaccine design against Zika virus. Eur J Med Chem 2018,156,444-460","journal-title":"Eur J Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ejmech.2014.10.010","volume":"87","author":"Bhakat S.","year":"2014","unstructured":"Bhakat S.; Karubiu W.; Jayaprakash V.; Soliman M.E.S.; A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses. Eur J Med Chem 2014,87,677-702","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbrc.2017.01.041","volume":"492","author":"da Fonseca N.J.","year":"2017","unstructured":"da Fonseca N.J.; Lima Afonso M.Q.; Pedersolli N.G.; de Oliveira L.C.; Andrade D.S.; Bleicher L.; Sequence, structure and function relationships in flaviviruses as assessed by evolutive aspects of its conserved non-structural protein domains. Biochem Biophys Res Commun 2017,492(4),565-571","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0166-0934(90)90075-Q","volume":"30","author":"Falconar A.K.I.","year":"1990","unstructured":"Falconar A.K.I.; Young P.R.; Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1. J Virol Methods 1990,30(3),323-332","journal-title":"J Virol Methods"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","volume":"13","author":"Rastogi M.","year":"2016","unstructured":"Rastogi M.; Sharma N.; Singh S.K.; Flavivirus NS1: A multifaceted enigmatic viral protein. Virol J 2016,13(1),131","journal-title":"Virol J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2016.02.014","volume":"130","author":"Watterson D.","year":"2016","unstructured":"Watterson D.; Modhiran N.; Young P.R.; The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. Antiviral Res 2016,130,7-18","journal-title":"Antiviral Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/bies.201400182","volume":"37","author":"Akey D.L.","year":"2015","unstructured":"Akey D.L.; Brown W.C.; Jose J.; Kuhn R.J.; Smith J.L.; Structure-guided insights on the role of NS1 in flavivirus infection. BioEssays 2015,37(5),489-494","journal-title":"BioEssays"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/v9100291","volume":"9","author":"Chen S.","year":"2017","unstructured":"Chen S.; Wu Z.; Wang M.; Cheng A.; Innate immune evasion mediated by flaviviridae non-structural proteins. Viruses 2017,9(10),291","journal-title":"Viruses"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.virol.2008.11.003","volume":"384","author":"Zou G.","year":"2009","unstructured":"Zou G.; Puig-Basagoiti F.; Zhang B.; Qing M.; Chen L.; Pankiewicz K.W.; Felczak K.; Yuan Z.; Shi P.Y.; A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology 2009,384(1),242-252","journal-title":"Virology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","volume":"81","author":"Sampath A.","year":"2009","unstructured":"Sampath A.; Padmanabhan R.; Molecular targets for flavivirus drug discovery. Antiviral Res 2009,81(1),6-15","journal-title":"Antiviral Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1128\/JVI.05468-11","volume":"85","author":"Xie X.","year":"2011","unstructured":"Xie X.; Wang Q.Y.; Xu H.Y.; Qing M.; Kramer L.; Yuan Z.; Shi P.Y.; Inhibition of dengue virus by targeting viral NS4B protein. J Virol 2011,85(21),11183-11195","journal-title":"J Virol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1016\/j.bbamem.2012.06.022","volume":"1818","author":"Nem&#xE9;sio H.","year":"2012","unstructured":"Nem&#xE9;sio H.; Palomares-Jerez F.; Villala&#xED;n J.; NS4A and NS4B proteins from dengue virus: Membranotropic regions. Biochim Biophys Acta Biomembr 2012,1818(11),2818-2830","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.03.007","volume":"118","author":"Xie X.","year":"2015","unstructured":"Xie X.; Zou J.; Wang Q.Y.; Shi P.Y.; Targeting dengue virus NS4B protein for drug discovery. Antiviral Res 2015,118,39-45","journal-title":"Antiviral Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","volume":"87","author":"Bollati M.","year":"2010","unstructured":"Bollati M.; Alvarez K.; Assenberg R.; Baronti C.; Canard B.; Cook S.; Coutard B.; Decroly E.; de Lamballerie X.; Gould E.A.; Grard G.; Grimes J.M.; Hilgenfeld R.; Jansson A.M.; Malet H.; Mancini E.J.; Mastrangelo E.; Mattevi A.; Milani M.; Moureau G.; Neyts J.; Owens R.J.; Ren J.; Selisko B.; Speroni S.; Steuber H.; Stuart D.I.; Unge T.; Bolognesi M.; Structure and functionality in flavivirus NS-proteins: Perspectives for drug design. Antiviral Res 2010,87(2),125-148","journal-title":"Antiviral Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JVI.00855-15","volume":"89","author":"Wang Q.Y.","year":"2015","unstructured":"Wang Q.Y.; Dong H.; Zou B.; Karuna R.; Wan K.F.; Zou J.; Susila A.; Yip A.; Shan C.; Yeo K.L.; Xu H.; Ding M.; Chan W.L.; Gu F.; Seah P.G.; Liu W.; Lakshminarayana S.B.; Kang C.; Lescar J.; Blasco F.; Smith P.W.; Shi P.Y.; Discovery of dengue virus NS4B inhibitors. J Virol 2015,89(16),8233-8244","journal-title":"J Virol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.stem.2016.07.019","volume":"19","author":"Liang Q.","year":"2016","unstructured":"Liang Q.; Luo Z.; Zeng J.; Chen W.; Foo S.S.; Lee S.A.; Ge J.; Wang S.; Goldman S.A.; Zlokovic B.V.; Zhao Z.; Jung J.U.; Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR signaling in human fetal neural stem cells to inhibit neurogenesis and induce autophagy. Cell Stem Cell 2016,19(5),663-671","journal-title":"Cell Stem Cell"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00018-018-2751-x","volume":"75","author":"Wang B.","year":"2018","unstructured":"Wang B.; Thurmond S.; Hai R.; Song J.; Structure and function of Zika virus NS5 protein: Perspectives for drug design. Cell Mol Life Sci 2018,75(10),1723-1736","journal-title":"Cell Mol Life Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1021\/bi300406n","volume":"51","author":"Bussetta C.","year":"2012","unstructured":"Bussetta C.; Choi K.H.; Dengue virus nonstructural protein 5 adopts multiple conformations in solution. Biochemistry 2012,51(30),5921-5931","journal-title":"Biochemistry"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/07391102.2017.1313175","volume":"36","author":"Ramharack P.","year":"2018","unstructured":"Ramharack P.; Soliman M.E.S.; Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery. J Biomol Struct Dyn 2018,36(5),1118-1133","journal-title":"J Biomol Struct Dyn"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","volume":"119","author":"Lim S.P.","year":"2015","unstructured":"Lim S.P.; Noble C.G.; Shi P.Y.; The dengue virus NS5 protein as a target for drug discovery. Antiviral Res 2015,119,57-67","journal-title":"Antiviral Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbrc.2016.11.098","volume":"492","author":"Zhang C.","year":"2017","unstructured":"Zhang C.; Feng T.; Cheng J.; Li Y.; Yin X.; Zeng W.; Jin X.; Li Y.; Guo F.; Jin T.; Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design. Biochem Biophys Res Commun 2017,492(4),624-630","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pep.2015.04.008","volume":"112","author":"Kamkaew M.","year":"2015","unstructured":"Kamkaew M.; Chimnaronk S.; Characterization of soluble RNA-dependent RNA polymerase from dengue virus serotype 2: The polyhistidine tag compromises the polymerase activity. Protein Expr Purif 2015,112,43-49","journal-title":"Protein Expr Purif"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1128\/JVI.00002-08","volume":"82","author":"Leung J.Y.","year":"2008","unstructured":"Leung J.Y.; Pijlman G.P.; Kondratieva N.; Hyde J.; Mackenzie J.M.; Khromykh A.A.; Role of nonstructural protein NS2A in flavivirus assembly. J Virol 2008,82(10),4731-4741","journal-title":"J Virol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"e02375","DOI":"10.1128\/mBio.02375-19","volume":"10","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Xie X.; Xia H.; Zou J.; Huang L.; Popov V.L.; Chen X.; Shi P.Y.; Zika Virus NS2A-mediated virion assembly. MBio 2019,10(5),e02375-19","journal-title":"MBio"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2020.12.007","volume":"46","author":"Barnard T.R.","year":"2021","unstructured":"Barnard T.R.; Abram Q.H.; Lin Q.F.; Wang A.B.; Sagan S.M.; Molecular determinants of flavivirus virion assembly. Trends Biochem Sci 2021,46(5),378-390","journal-title":"Trends Biochem Sci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1099\/0022-1317-69-1-23","volume":"69","author":"Speight G.","year":"1988","unstructured":"Speight G.; Coia G.; Parker M.D.; Westaway E.G.; Gene mapping and positive identification of the non-structural proteins NS2A, NS2B, NS3, NS4B and NS5 of the flavivirus Kunjin and their cleavage sites. J Gen Virol 1988,69(1),23-34","journal-title":"J Gen Virol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e01836","DOI":"10.1128\/JVI.01836-16","volume":"91","author":"Wu R.H.","year":"2017","unstructured":"Wu R.H.; Tsai M.H.; Tsai K.N.; Tian J.N.; Wu J.S.; Wu S.Y.; Chern J.H.; Chen C.H.; Yueh A.; Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments. J Virol 2017,91(12),e01836-16","journal-title":"J Virol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.1128\/JVI.78.22.12225-12235.2004","volume":"78","author":"Liu W.J.","year":"2004","unstructured":"Liu W.J.; Chen H.B.; Wang X.J.; Huang H.; Khromykh A.A.; Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 2004,78(22),12225-12235","journal-title":"J Virol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1128\/jvi.64.9.4364-4374.1990","volume":"64","author":"Preugschat F.","year":"1990","unstructured":"Preugschat F.; Yao C.W.; Strauss J.H.; In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol 1990,64(9),4364-4374","journal-title":"J Virol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrmicro1928","volume":"6","author":"Murray C.L.","year":"2008","unstructured":"Murray C.L.; Jones C.T.; Rice C.M.; Architects of assembly: Roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol 2008,6(9),699-708","journal-title":"Nat Rev Microbiol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bcp.2018.04.008","volume":"154","author":"Gopala Reddy S.B.","year":"2018","unstructured":"Gopala Reddy S.B.; Chin W.X.; Shivananju N.S.; Dengue virus NS2 and NS4: Minor proteins, mammoth roles. Biochem Pharmacol 2018,154,54-63","journal-title":"Biochem Pharmacol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1099\/0022-1317-80-5-1167","volume":"80","author":"Brinkworth R.I.","year":"1999","unstructured":"Brinkworth R.I.; Fairlie D.P.; Leung D.; Young P.R.; Homology model of the dengue 2 virus NS3 protease: Putative interactions with both substrate and NS2B cofactor. J Gen Virol 1999,80(5),1167-1177","journal-title":"J Gen Virol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1128\/jvi.67.4.2034-2042.1993","volume":"67","author":"Falgout B.","year":"1993","unstructured":"Falgout B.; Miller R.H.; Lai C.J.; Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol 1993,67(4),2034-2042","journal-title":"J Virol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","volume":"118","author":"Luo D.","year":"2015","unstructured":"Luo D.; Vasudevan S.G.; Lescar J.; The flavivirus NS2B\u2013NS3 protease\u2013helicase as a target for antiviral drug development. Antiviral Res 2015,118,148-158","journal-title":"Antiviral Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nsmb.3258","volume":"23","author":"Jain R.","year":"2016","unstructured":"Jain R.; Coloma J.; Garc&#xED;a-Sastre A.; Aggarwal A.K.; Structure of the NS3 helicase from Zika virus. Nat Struct Mol Biol 2016,23(8),752-754","journal-title":"Nat Struct Mol Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1471-2180-11-234","volume":"11","author":"Le Breton M.","year":"2011","unstructured":"Le Breton M.; Meyniel-Schicklin L.; Deloire A.; Coutard B.; Canard B.; de Lamballerie X.; Andre P.; Rabourdin-Combe C.; Lotteau V.; Davoust N.; Flavivirus NS3 and NS5 proteins interaction network: A high-throughput yeast two-hybrid screen. BMC Microbiol 2011,11(1),234","journal-title":"BMC Microbiol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"12883","DOI":"10.1074\/jbc.M611318200","volume":"282","author":"Bera A.K.","year":"2007","unstructured":"Bera A.K.; Kuhn R.J.; Smith J.L.; Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease. J Biol Chem 2007,282(17),12883-12892","journal-title":"J Biol Chem"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","volume":"67","author":"Mastrangelo E.","year":"2012","unstructured":"Mastrangelo E.; Pezzullo M.; De Burghgraeve T.; Kaptein S.; Pastorino B.; Dallmeier K.; de Lamballerie X.; Neyts J.; Hanson A.M.; Frick D.N.; Bolognesi M.; Milani M.; Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: New prospects for an old drug. J Antimicrob Chemother 2012,67(8),1884-1894","journal-title":"J Antimicrob Chemother"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.tim.2017.07.001","volume":"25","author":"Kang C.","year":"2017","unstructured":"Kang C.; Keller T.H.; Luo D.; Zika virus protease: an antiviral drug target. Trends Microbiol 2017,25(10),797-808","journal-title":"Trends Microbiol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"12895","DOI":"10.1128\/JVI.00942-09","volume":"83","author":"Assenberg R.","year":"2009","unstructured":"Assenberg R.; Mastrangelo E.; Walter T.S.; Verma A.; Milani M.; Owens R.J.; Stuart D.I.; Grimes J.M.; Mancini E.J.; Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol 2009,83(24),12895-12906","journal-title":"J Virol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","volume":"80","author":"Lescar J.","year":"2008","unstructured":"Lescar J.; Luo D.; Xu T.; Sampath A.; Lim S.; Canard B.; Vasudevan S.; Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res 2008,80(2),94-101","journal-title":"Antiviral Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","volume":"150","author":"Li Z.","year":"2018","unstructured":"Li Z.; Sakamuru S.; Huang R.; Brecher M.; Koetzner C.A.; Zhang J.; Chen H.; Qin C.; Zhang Q.Y.; Zhou J.; Kramer L.D.; Xia M.; Li H.; Erythrosin B.; Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Antiviral Res 2018,150,217-225","journal-title":"Antiviral Res"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.2174\/1389557522666220404085858","volume":"22","author":"dos Santos Nascimento I.J.","year":"2022","unstructured":"dos Santos Nascimento I.J.; da Silva Santos-J&#xFA;nior P.F.; de Ara&#xFA;jo-J&#xFA;nior J.X.; da Silva-J&#xFA;nior E.F.; Strategies in medicinal chemistry to discovery new hits compounds against ebola virus: Challenges and perspectives in drug discovery. Mini Rev Med Chem 2022,22(22),2896-2924","journal-title":"Mini Rev Med Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.2174\/1568026621666210331152702","volume":"21","author":"dos Santos Nascimento I.J.","year":"2021","unstructured":"dos Santos Nascimento I.J.; de Aquino T.M.; da Silva-J&#xFA;nior E.F.; Cruzain and Rhodesain Inhibitors: Last Decade of advances in seeking for new compounds against American and African Trypanosomiases. Curr Top Med Chem 2021,21(21),1871-1899","journal-title":"Curr Top Med Chem"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jmr.977","volume":"23","author":"Wichapong K.","year":"2010","unstructured":"Wichapong K.; Pianwanit S.; Sippl W.; Kokpol S.; Homology modeling and molecular dynamics simulations of dengue virus ns2b\/ns3 protease: insight into molecular interaction. J Mol Recognit 2010,23(3),283-300","journal-title":"J Mol Recognit"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jmgm.2015.05.008","volume":"60","author":"Yotmanee P.","year":"2015","unstructured":"Yotmanee P.; Rungrotmongkol T.; Wichapong K.; Choi S.B.; Wahab H.A.; Kungwan N.; Hannongbua S.; Binding specificity of polypeptide substrates in NS2B\/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study. J Mol Graph Model 2015,60,24-33","journal-title":"J Mol Graph Model"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jmgm.2019.08.001","volume":"92","author":"Nutho B.","year":"2019","unstructured":"Nutho B.; Rungrotmongkol T.; Binding recognition of substrates in NS2B\/NS3 serine protease of Zika virus revealed by molecular dynamics simulations. J Mol Graph Model 2019,92,227-235","journal-title":"J Mol Graph Model"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12013-016-0741-x","volume":"74","author":"Lavanya P.","year":"2016","unstructured":"Lavanya P.; Ramaiah S.; Anbarasu A.; Ethyl 4-(4-methylphenyl)-4-pentenoate from Vetiveria zizanioides Inhibits Dengue NS2B\u2013NS3 protease and prevents viral assembly: A computational molecular dynamics and docking study. Cell Biochem Biophys 2016,74(3),337-351","journal-title":"Cell Biochem Biophys"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bioorg.2015.07.005","volume":"62","author":"Timiri A.K.","year":"2015","unstructured":"Timiri A.K.; Selvarasu S.; Kesherwani M.; Vijayan V.; Sinha B.N.; Devadasan V.; Jayaprakash V.; Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors. Bioorg Chem 2015,62,74-82","journal-title":"Bioorg Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jmgm.2016.03.008","volume":"66","author":"Mirza S.B.","year":"2016","unstructured":"Mirza S.B.; Salmas R.E.; Fatmi M.Q.; Durdagi S.; Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study. J Mol Graph Model 2016,66,99-107","journal-title":"J Mol Graph Model"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.antiviral.2018.10.019","volume":"160","author":"Coronado M.A.","year":"2018","unstructured":"Coronado M.A.; Eberle R.J.; Bleffert N.; Feuerstein S.; Olivier D.S.; de Moraes F.R.; Willbold D.; Arni R.K.; Zika virus NS2B\/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B\/NS3 proteinase inhibition-. Antiviral Res 2018,160,118-125","journal-title":"Antiviral Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acsmedchemlett.1c00653","volume":"13","author":"Lin X.","year":"2022","unstructured":"Lin X.; Cheng J.; Wu Y.; Zhang Y.; Jiang H.; Wang J.; Wang X.; Cheng M.; Identification and in silico binding study of a highly potent DENV NS2B-NS3 covalent inhibitor. ACS Med Chem Lett 2022,13(4),599-607","journal-title":"ACS Med Chem Lett"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/prot.25809","volume":"88","author":"Ren J.","year":"2020","unstructured":"Ren J.; Lee H.; Kotak A.; Johnson M.E.; MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B\/NS3 protease. Proteins 2020,88(2),345-354","journal-title":"Proteins"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biochi.2020.04.014","volume":"174","author":"Behnam M.A.M.","year":"2020","unstructured":"Behnam M.A.M.; Klein C.D.P.; Conformational selection in the flaviviral NS2B-NS3 protease. Biochimie 2020,174,117-125","journal-title":"Biochimie"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/cmdc.202100246","volume":"16","author":"Kronenberger T.","year":"2021","unstructured":"Kronenberger T.; S&#xE1; Magalh&#xE3;es Serafim M.; Kumar Tonduru A.; Gon&#xE7;alves Maltarollo V.; Poso A.; Ligand accessibility insights to the dengue virus NS3\u2010NS2B protease assessed by long\u2010timescale molecular dynamics simulations. ChemMedChem 2021,16(16),2524-2534","journal-title":"ChemMedChem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2021.01.014","volume":"556","author":"Kumar A.","year":"2021","unstructured":"Kumar A.; Kumar P.; Aarthy M.; Singh S.K.; Giri R.; Experiments and simulation on ZIKV NS2B-NS3 protease reveal its complex folding. Virology 2021,556,110-123","journal-title":"Virology"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jmgm.2014.06.008","volume":"52","author":"Mukhametov A.","year":"2014","unstructured":"Mukhametov A.; Newhouse E.I.; Aziz N.A.; Saito J.A.; Alam M.; Allosteric pocket of the dengue virus (serotype 2) NS2B\/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition. J Mol Graph Model 2014,52,103-113","journal-title":"J Mol Graph Model"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbrc.2017.03.107","volume":"492","author":"Aguilera-Pesantes D.","year":"2017","unstructured":"Aguilera-Pesantes D.; Robayo L.E.; M&#xE9;ndez P.E.; Mollocana D.; Marrero-Ponce Y.; Torres F.J.; M&#xE9;ndez M.A.; Discovering key residues of dengue virus NS2b-NS3-protease: New binding sites for antiviral inhibitors design. Biochem Biophys Res Commun 2017,492(4),631-642","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"25677","DOI":"10.1021\/acsomega.0c00039","volume":"5","author":"Lim L.","year":"2020","unstructured":"Lim L.; Dang M.; Roy A.; Kang J.; Song J.; Curcumin allosterically inhibits the dengue NS2B-NS3 protease by disrupting its active conformation. ACS Omega 2020,5(40),25677-25686","journal-title":"ACS Omega"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acs.jcim.1c01326","volume":"62","author":"Santos N.P.","year":"2022","unstructured":"Santos N.P.; Santos L.H.; Torquato Quezado de Magalh&#xE3;es M.; Lei J.; Hilgenfeld R.; Salgado Ferreira R.; Bleicher L.; Characterization of an allosteric pocket in zika virus NS2B-NS3 protease. J Chem Inf Model 2022,62(4),945-957","journal-title":"J Chem Inf Model"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"19059","DOI":"10.1038\/s41598-019-55723-5","volume":"9","author":"Bharadwaj S.","year":"2019","unstructured":"Bharadwaj S.; Lee K.E.; Dwivedi V.D.; Yadava U.; Panwar A.; Lucas S.J.; Pandey A.; Kang S.G.; Discovery of ganoderma lucidum triterpenoids as potential inhibitors against dengue virus NS2B-NS3 protease. Sci Rep 2019,9(1),19059","journal-title":"Sci Rep"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/molecules27082562","volume":"27","author":"Kumar S.","year":"2022","unstructured":"Kumar S.; El-Kafrawy S.A.; Bharadwaj S.; Maitra S.S.; Alandijany T.A.; Faizo A.A.; Khateb A.M.; Dwivedi V.D.; Azhar E.I.; Discovery of bispecific lead compounds from Azadirachta indica against ZIKA NS2B-NS3 protease and NS5 RNA dependent RNA polymerase using molecular simulations. Molecules 2022,27(8),2562","journal-title":"Molecules"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"104719","DOI":"10.1016\/j.bioorg.2021.104719","volume":"109","author":"Lima C.S.","year":"2021","unstructured":"Lima C.S.; Mottin M.; de Assis L.R.; Mesquita N.C.M.R.; Sousa B.K.P.; Coimbra L.D.; Santos K.B.; Zorn K.M.; Guido R.V.C.; Ekins S.; Marques R.E.; Proen&#xE7;a-Modena J.L.; Oliva G.; Andrade C.H.; Regasini L.O.; Flavonoids from pterogyne nitens as zika virus NS2B-NS3 protease inhibitors. Bioorg Chem 2021,109,104719","journal-title":"Bioorg Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/molecules27030653","volume":"27","author":"Shimu M.S.S.","year":"2022","unstructured":"Shimu M.S.S.; Mahmud S.; Tallei T.E.; Sami S.A.; Adam A.A.; Acharjee U.K.; Paul G.K.; Emran T.B.; Zaman S.; Uddin M.S.; Saleh M.A.; Alshehri S.; Ghoneim M.M.; Alruwali M.; Obaidullah A.J.; Jui N.R.; Kim J.; Kim B.; Phytochemical compound screening to identify novel small molecules against dengue virus: A docking and dynamics study. Molecules 2022,27(3),653","journal-title":"Molecules"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"100932","DOI":"10.1016\/j.imu.2022.100932","volume":"30","author":"Hasan M.","year":"2022","unstructured":"Hasan M.; Mia M.M.; Munna S.U.; Talha M.M.H.; Das K.; Seawater fungi-derived compound screening to identify novel small molecules against dengue virus NS5 methyltransferase and NS2B\/NS3 protease. Inform Med Unlocked 2022,30,100932","journal-title":"Inform Med Unlocked"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"e1006411","DOI":"10.1371\/journal.ppat.1006411","volume":"13","author":"Brecher M.","year":"2017","unstructured":"Brecher M.; Li Z.; Liu B.; Zhang J.; Koetzner C.A.; Alifarag A.; Jones S.A.; Lin Q.; Kramer L.D.; Li H.; A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease. PLoS Pathog 2017,13(5),e1006411","journal-title":"PLoS Pathog"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","volume":"139","author":"Lee H.","year":"2017","unstructured":"Lee H.; Ren J.; Nocadello S.; Rice A.J.; Ojeda I.; Light S.; Minasov G.; Vargas J.; Nagarathnam D.; Anderson W.F.; Johnson M.E.; Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus. Antiviral Res 2017,139,49-58","journal-title":"Antiviral Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","volume":"141","author":"Chan J.F.W.","year":"2017","unstructured":"Chan J.F.W.; Chik K.K.H.; Yuan S.; Yip C.C.Y.; Zhu Z.; Tee K.M.; Tsang J.O.L.; Chan C.C.S.; Poon V.K.M.; Lu G.; Zhang A.J.; Lai K.K.; Chan K.H.; Kao R.Y.T.; Yuen K.Y.; Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antiviral Res 2017,141,29-37","journal-title":"Antiviral Res"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","volume":"143","author":"Shiryaev S.A.","year":"2017","unstructured":"Shiryaev S.A.; Farhy C.; Pinto A.; Huang C.T.; Simonetti N.; Ngono A.E.; Dewing A.; Shresta S.; Pinkerton A.B.; Cieplak P.; Strongin A.Y.; Terskikh A.V.; Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists. Antiviral Res 2017,143,218-229","journal-title":"Antiviral Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1021\/acsomega.8b01002","volume":"3","author":"Kumar A.","year":"2018","unstructured":"Kumar A.; Liang B.; Aarthy M.; Singh S.K.; Garg N.; Mysorekar I.U.; Giri R.; Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease. ACS Omega 2018,3(12),18132-18141","journal-title":"ACS Omega"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/molecules24081465","volume":"24","author":"Zhu S.","year":"2019","unstructured":"Zhu S.; Zhang C.; Huang L.S.; Zhang X.Q.; Xu Y.; Fang X.; Zhou J.; Wu M.; Schooley R.T.; Huang Z.; An J.; Discovery and computational analyses of novel small molecule Zika Virus Inhibitors. Molecules 2019,24(8),1465","journal-title":"Molecules"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/acsmedchemlett.9b00405","volume":"11","author":"Coluccia A.","year":"2020","unstructured":"Coluccia A.; Puxeddu M.; Nalli M.; Wei C.K.; Wu Y.H.; Mastrangelo E.; Elamin T.; Tarantino D.; Bugert J.J.; Schreiner B.; Nolte J.; Schwarze F.; La Regina G.; Lee J.C.; Silvestri R.; Discovery of Zika Virus NS2B\/NS3 inhibitors that prevent mice from life-threatening infection and brain damage. ACS Med Chem Lett 2020,11(10),1869-1874","journal-title":"ACS Med Chem Lett"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1021\/acs.jcim.9b00933","volume":"60","author":"Santos F.R.S.","year":"2020","unstructured":"Santos F.R.S.; Nunes D.A.F.; Lima W.G.; Davyt D.; Santos L.L.; Taranto A.G.; M S Ferreira; J. Identification of zika virus NS2B-NS3 protease inhibitors by structure-based virtual screening and drug repurposing approaches. J Chem Inf Model 2020,60(2),731-737","journal-title":"J Chem Inf Model"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/microorganisms9030545","volume":"9","author":"Shin H.J.","year":"2021","unstructured":"Shin H.J.; Kim M.H.; Lee J.Y.; Hwang I.; Yoon G.Y.; Kim H.S.; Kwon Y.C.; Ahn D.G.; Kim K.D.; Kim B.T.; Kim S.J.; Kim C.; Structure-based virtual screening: Identification of a Novel NS2B-NS3 Protease inhibitor with potent antiviral activity against zika and dengue viruses. Microorganisms 2021,9(3),545","journal-title":"Microorganisms"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.antiviral.2020.104707","volume":"175","author":"Quek J.P.","year":"2020","unstructured":"Quek J.P.; Liu S.; Zhang Z.; Li Y.; Ng E.Y.; Loh Y.R.; Hung A.W.; Luo D.; Kang C.; Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease. Antiviral Res 2020,175,104707","journal-title":"Antiviral Res"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12010-018-2814-3","volume":"187","author":"Rohini K.","year":"2019","unstructured":"Rohini K.; Agarwal P.; Preethi B.; Shanthi V.; Ramanathan K.; Exploring the lead compounds for Zika virus NS2B-NS3 protein: an e-pharmacophore-based approach. Appl Biochem Biotechnol 2019,187(1),194-210","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1021\/acsmedchemlett.9b00629","volume":"11","author":"Pach S.","year":"2020","unstructured":"Pach S.; Sarter T.M.; Yousef R.; Schaller D.; Bergemann S.; Arkona C.; Rademann J.; Nitsche C.; Wolber G.; Catching a moving target: comparative modeling of flaviviral NS2B-NS3 reveals small molecule Zika protease inhibitors. ACS Med Chem Lett 2020,11(4),514-520","journal-title":"ACS Med Chem Lett"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10822-010-9326-8","volume":"24","author":"Frecer V.","year":"2010","unstructured":"Frecer V.; Miertus S.; Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of dengue virus NS2B-NS3 protease. J Comput Aided Mol Des 2010,24(3),195-212","journal-title":"J Comput Aided Mol Des"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1021\/acs.jpcb.9b02157","volume":"123","author":"Nutho B.","year":"2019","unstructured":"Nutho B.; Mulholland A.J.; Rungrotmongkol T.; Quantum mechanics\/molecular mechanics (QM\/MM) calculations support a concerted reaction mechanism for the zika virus NS2B\/NS3 serine protease with its substrate. J Phys Chem B 2019,123(13),2889-2903","journal-title":"J Phys Chem B"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","volume":"163","author":"Lim S.P.","year":"2019","unstructured":"Lim S.P.; Dengue drug discovery: Progress, challenges and outlook. Antiviral Res 2019,163,156-178","journal-title":"Antiviral Res"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.virol.2020.01.015","volume":"543","author":"Pielnaa P.","year":"2020","unstructured":"Pielnaa P.; Al-Saadawe M.; Saro A.; Dama M.F.; Zhou M.; Huang Y.; Huang J.; Xia Z.; Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology 2020,543,34-42","journal-title":"Virology"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/17460441.2020.1811675","volume":"16","author":"Idris F.","year":"2021","unstructured":"Idris F.; Ting D.H.R.; Alonso S.; An update on dengue vaccine development, challenges, and future perspectives. Expert Opin Drug Discov 2021,16(1),47-58","journal-title":"Expert Opin Drug Discov"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00436-013-3342-2","volume":"112","author":"Gupta B.","year":"2013","unstructured":"Gupta B.; Reddy B.P.N.; Fight against dengue in India: Progresses and challenges. Parasitol Res 2013,112(4),1367-1378","journal-title":"Parasitol Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"834371","DOI":"10.1155\/2015\/834371","volume":"2015","author":"Mardekian S.K.","year":"2015","unstructured":"Mardekian S.K.; Roberts A.L.; Diagnostic options and challenges for dengue and chikungunya viruses. BioMed Res Int 2015,2015,834371","journal-title":"BioMed Res Int"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","volume":"100","author":"Lim S.P.","year":"2013","unstructured":"Lim S.P.; Wang Q.Y.; Noble C.G.; Chen Y.L.; Dong H.; Zou B.; Yokokawa F.; Nilar S.; Smith P.; Beer D.; Lescar J.; Shi P.Y.; Ten years of dengue drug discovery: Progress and prospects. Antiviral Res 2013,100(2),500-519","journal-title":"Antiviral Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1021\/ci900056c","volume":"49","author":"Cross J.B.","year":"2009","unstructured":"Cross J.B.; Thompson D.C.; Rai B.K.; Baber J.C.; Fan K.Y.; Hu Y.; Humblet C.; Comparison of several molecular docking programs: pose prediction and virtual screening accuracy. J Chem Inf Model 2009,49(6),1455-1474","journal-title":"J Chem Inf Model"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1021\/ci700052x","volume":"47","author":"McGaughey G.B.","year":"2007","unstructured":"McGaughey G.B.; Sheridan R.P.; Bayly C.I.; Culberson J.C.; Kreatsoulas C.; Lindsley S.; Maiorov V.; Truchon J.F.; Cornell W.D.; Comparison of topological, shape, and docking methods in virtual screening. J Chem Inf Model 2007,47(4),1504-1519","journal-title":"J Chem Inf Model"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"126965","DOI":"10.1016\/j.bmcl.2020.126965","volume":"30","author":"Voss S.","year":"2020","unstructured":"Voss S.; Nitsche C.; Inhibitors of the Zika virus protease NS2B-NS3. Bioorg Med Chem Lett 2020,30(5),126965","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/acschembio.7b00903","volume":"13","author":"Baell J.B.","year":"2018","unstructured":"Baell J.B.; Nissink J.W.M.; Seven year itch: pan-assay interference compounds (PAINS) in 2017-utility and limitations. ACS Chem Biol 2018,13(1),36-44","journal-title":"ACS Chem Biol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"583826","DOI":"10.3389\/fmolb.2020.583826","volume":"7","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Wang G.; Moitessier N.; Mittermaier A.K.; Enzyme kinetics by isothermal titration calorimetry: Allostery, inhibition, and dynamics. Front Mol Biosci 2020,7,583826","journal-title":"Front Mol Biosci"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4939-9179-2_5","volume":"1964","author":"Paketuryt\u0117 V.","year":"2019","unstructured":"Paketuryt\u0117 V.; Zubrien\u0117 A.; Ladbury J.E.; Matulis D.; Intrinsic thermodynamics of protein-ligand binding by isothermal titration calorimetry as aid to drug design. Methods Mol Biol 2019,1964,61-74","journal-title":"Methods Mol Biol"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221122121330","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211122\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026623666221122121330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T15:39:05Z","timestamp":1701445145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211122\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":171,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026623666221122121330","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}